AstraZeneca PLC Operating Cycle 2011-2026 | AZN

Annual Operating Cycle AstraZeneca PLC

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-	-	-	-	-	-	-	-	-	206	168	122	132	139	112

All numbers in USD currency

Maximum	Minimum	Average
206	112	147

Issuer	Operating Cycle	Price	% 24h	Market Cap	Country
BioCardia BCDA	101	$ 1.36	5.04 %	$ 28.8 M	USA
I-Mab IMAB	271	-	-	$ 866 M	China
Alexion Pharmaceuticals, Inc. ALXN	12.8	-	-	$ 40.3 B	USA
AgeX Therapeutics AGE	78.4	-	-10.17 %	$ 12.2 K	USA
BioXcel Therapeutics BTAI	244	$ 1.63	-2.37 %	$ 4.13 M	USA
AbCellera Biologics ABCL	173	$ 3.65	0.97 %	$ 1.09 B	Canada
EyeGate Pharmaceuticals, Inc. EYEG	32	-	-1.52 %	$ 24.7 M	USA
Midatech Pharma plc MTP	245	-	-18.52 %	$ 27.3 M	Britain
Acorda Therapeutics ACOR	394	-	-24.86 %	$ 820 K	USA
Acasti Pharma ACST	1.97	-	4.01 %	$ 150 M	Canada
Catalyst Biosciences CBIO	410	$ 11.55	-4.47 %	$ 760 M	USA
Институт стволовых клеток человека ISKJ	104	-	-	-	Russia
AIkido Pharma AIKI	17.9	-	1.93 %	$ 17.4 M	USA
C4 Therapeutics CCCC	27.9	$ 3.04	12.59 %	$ 252 M	USA
Albireo Pharma ALBO	40.8	-	-0.23 %	$ 916 M	USA
Codexis CDXS	50.2	$ 1.08	6.93 %	$ 79.3 M	USA
Alpine Immune Sciences ALPN	154	-	-	$ 2.17 B	USA
Cerus Corporation CERS	59.2	$ 2.64	2.93 %	$ 487 M	USA
Certara CERT	89.6	$ 7.17	1.2 %	$ 1.15 B	USA
Aeterna Zentaris AEZS	115	-	5.93 %	$ 314 M	Canada
Compugen Ltd. CGEN	60.8	$ 2.24	23.76 %	$ 201 M	Israel
Coherus BioSciences CHRS	379	$ 1.66	-0.9 %	$ 156 M	USA
Aptinyx APTX	46.9	-	-39.0 %	$ 4.57 M	USA
Celldex Therapeutics CLDX	321	$ 30.18	0.3 %	$ 2 B	USA
Cellectis S.A. CLLS	136	$ 3.88	-	$ 116 M	France